Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEISB.L Regulatory News (EISB)

  • There is currently no data for EISB

Pre-Close Trading Statement

21 Jul 2022 07:00

RNS Number : 1990T
East Imperial PLC
21 July 2022
 

21 July 2022

East Imperial PLC

Pre-Close Trading Statement

Record performance in June following a half of strong sales and operational progress in key markets 

East Imperial, the global purveyor of ultra-premium mixers, announces a pre-close trading statement for the six months ended 30 June 2022, ahead of reporting its interim results in September 2022.

In the first six months of the year, the group sold 95,780 cases globally across 28 markets, resulting in revenue moving 32% higher compared to the same period in 2021, driven by both the addition of new customers and strong demand from the existing base.

In East Imperial's established APAC market, sales in the period were ahead of the Board's expectations as COVID restrictions continue to lift in key markets, with New Zealand and Singapore now returning to pre-COVID levels of demand.

In the key strategic US market, revenue was 37% higher than budget, with June being East Imperial's biggest ever month of sales. The US team has been bolstered by experienced senior hires from the world of luxury beverages and the company now has a strong distribution network in place via a long-term agreement with Republic National Distributing Company (RNDC), one of the largest distributors in the US. RNDC initially began distributing East Imperial's mixers across eight key US states in March 2022 and given the success seen to date, plans are now in place to expand into more states over the next few months.

The company was the proud winner of eight medals, including two Best-in-Class, at the Spirits Business Awards in April 2022 as East Imperial's commitment to offering ultra-premium mixers made with the highest quality ingredients was recognised.

Global consumer trends in the beverage industry continue to shift towards ultra-premium drinks consumption, reinforcing the company's strategy for long-term sustainable growth.

Tony Burt, CEO of East Imperial, said:

"We're pleased with the performance of the business in the first six months of the current financial year. As well as achieving record sales in key strategic markets, we have also delivered important operational frameworks that provide a platform to enable us to drive sustainable sales growth in the months and years ahead.

While global logistic challenges remain, we are beginning to feel the benefits of the hard work our teams have done to put in place a strong bottling and distribution framework in the US. An operational priority for the rest of the year is to further enhance our bottling capability, to increase capacity and give us further flexibility as we embark on our national roll out with RNDC. We have an ongoing strategy to improve our margins, including actively reviewing our supply chain for ways to simplify the bottling and packaging process. We will see further margin improvement as we grow as we will also benefit from economies of scale. As an ultra-premium product, East Imperial's pricing also means that margins are holding up well.

While consumers more broadly are no doubt feeling the squeeze, the continuing shift towards premiumisation across the beverage industry means that demand for East Imperial's products remains very resilient despite inflationary pressures as people recognise the unparalleled quality of our product. I'm confident that this will cement our continued progress and deliver continued sales growth during the next six months, a period that is traditionally our dominant half of the year for sales. Our year to date performance encourages me that we have the right strategy and platform in place to drive long term sustainable growth to create value for our shareholders and we look forward to providing further details of our progress in September."

 

Media Enquiries

Brunswick Group

Helen Smith +44207404 5959

Will Booth

Eastimperial@brunswickgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIRDLIIFIF
Date   Source Headline
24th Nov 20227:00 amRNSAppointment of US Bottling Partner
17th Oct 202210:00 amRNSTR1 notification
14th Sep 202211:06 amRNSSecond Price Monitoring Extn
14th Sep 202211:00 amRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSInterim results
1st Sep 20227:10 amRNSAppointment of WH Ireland as Joint Broker
12th Aug 20229:05 amRNSSecond Price Monitoring Extn
12th Aug 20229:00 amRNSPrice Monitoring Extension
12th Aug 20227:00 amRNSChina Distribution Agreement
21st Jul 20227:00 amRNSPre-Close Trading Statement
1st Jun 20221:44 pmRNSResult of AGM
27th May 20222:00 pmRNSNotice of AGM: Correction
10th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFull Year Results
29th Apr 202212:40 pmRNSShort Delay to Publication of Annual Report
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20222:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20222:00 pmRNSPrice Monitoring Extension
25th Feb 20228:46 amRNSDirectorship Change
18th Feb 20229:47 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSUS Distribution Agreement
13th Jan 20227:00 amRNSPlacing and year-end update
10th Dec 20215:00 pmRNSDirector/PDMR Shareholding
9th Dec 20219:00 amRNSDirector/PDMR Shareholding
3rd Dec 20212:23 pmRNSDirectorate Changes and Withdrawal of Requisition
17th Nov 20217:00 amRNSRequisition of Extraordinary General Meeting
5th Nov 20217:00 amRNSSingapore Distribution Partner
1st Nov 20217:00 amRNSAppointment of Head of Sales for North America
19th Oct 20217:00 amRNSAppointments to new Strategic Advisory Board
29th Sep 202112:56 pmRNSShareholder Update
13th Sep 20217:00 amRNSTrading Update
13th Sep 20217:00 amRNSBermele Interim Accounts
7th Sep 20214:41 pmRNSSecond Price Monitoring Extn
7th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20212:05 pmRNSSecond Price Monitoring Extn
7th Sep 20212:00 pmRNSPrice Monitoring Extension
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
27th Aug 20219:05 amRNSSecond Price Monitoring Extn
27th Aug 20219:00 amRNSPrice Monitoring Extension
27th Aug 20217:37 amRNSNew Supply Agreements
16th Aug 20212:05 pmRNSSecond Price Monitoring Extn
16th Aug 20212:00 pmRNSPrice Monitoring Extension
6th Aug 20217:00 amRNSSupply Agreement
27th Jul 20214:40 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
27th Jul 20212:06 pmRNSSecond Price Monitoring Extn
27th Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jul 20217:00 amRNSChange of Name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.